Micro-RNA signature of lymphovascular space involvement in type 1 endometrial cancer

Lymphovascular space involvement (LVSI) is a major prognostic factor in type 1 endometrial cancer (EC). However, its use has been criticized because of poor subjectivity. MicroRNA signatures have recently been linked to EC pathologic characteristics. The aim of this study was to evaluate whether mic...

Full description

Saved in:
Bibliographic Details
Published inHistology and histopathology Vol. 32; no. 9; p. 941
Main Authors Canlorbe, Geoffroy, Castela, Mathieu, Bendifallah, Sofiane, Wang, Zhe, Lefevre, Marine, Chabbert-Buffet, Nathalie, Aractingi, Selim, DaraÏ, Emile, Méhats, Céline, Ballester, Marcos
Format Journal Article
LanguageEnglish
Published Spain 01.09.2017
Subjects
Online AccessGet more information

Cover

Loading…
Abstract Lymphovascular space involvement (LVSI) is a major prognostic factor in type 1 endometrial cancer (EC). However, its use has been criticized because of poor subjectivity. MicroRNA signatures have recently been linked to EC pathologic characteristics. The aim of this study was to evaluate whether microRNA profiles of type 1 EC can be related to LVSI status and used as a tool to adapt therapy. MicroRNA expression was assessed by chip analysis and qRT-PCR in 12 formalin-fixed paraffin-embedded grade 2 EC specimens with positive LVSI and in 12 specimens with negative LVSI. Various statistical analyses, including enrichment analysis and a minimum p-value approach, were performed. The expression levels of microRNAs 34c-5p, -23b-5p, and 23c were significantly lower in the EC with positive LVSI compared to those with negative LVSI. Women with a microRNA-34c-5p fold change <0.15 were more likely to have positive LVSI status (92.3%) compared with those with a microRNA-34c-5p fold change >0.15 (0.0%), p<0.001. Furthermore, women with a microRNA-23b-5p fold change <0.51 were more likely to have positive LVSI status (90.0%) compared with those with a microRNA-23b-5p fold change >0.51 (21.4%), p=0.003. This was the first study to investigate the relative expression of microRNA in type 1 EC according to LVSI status. This microRNA expression profile may provide a basis for further study of the microRNA function in EC, and be used as a diagnostic tool for LVSI status.
AbstractList Lymphovascular space involvement (LVSI) is a major prognostic factor in type 1 endometrial cancer (EC). However, its use has been criticized because of poor subjectivity. MicroRNA signatures have recently been linked to EC pathologic characteristics. The aim of this study was to evaluate whether microRNA profiles of type 1 EC can be related to LVSI status and used as a tool to adapt therapy. MicroRNA expression was assessed by chip analysis and qRT-PCR in 12 formalin-fixed paraffin-embedded grade 2 EC specimens with positive LVSI and in 12 specimens with negative LVSI. Various statistical analyses, including enrichment analysis and a minimum p-value approach, were performed. The expression levels of microRNAs 34c-5p, -23b-5p, and 23c were significantly lower in the EC with positive LVSI compared to those with negative LVSI. Women with a microRNA-34c-5p fold change <0.15 were more likely to have positive LVSI status (92.3%) compared with those with a microRNA-34c-5p fold change >0.15 (0.0%), p<0.001. Furthermore, women with a microRNA-23b-5p fold change <0.51 were more likely to have positive LVSI status (90.0%) compared with those with a microRNA-23b-5p fold change >0.51 (21.4%), p=0.003. This was the first study to investigate the relative expression of microRNA in type 1 EC according to LVSI status. This microRNA expression profile may provide a basis for further study of the microRNA function in EC, and be used as a diagnostic tool for LVSI status.
Author Wang, Zhe
Ballester, Marcos
Bendifallah, Sofiane
Aractingi, Selim
Méhats, Céline
Canlorbe, Geoffroy
DaraÏ, Emile
Castela, Mathieu
Chabbert-Buffet, Nathalie
Lefevre, Marine
Author_xml – sequence: 1
  givenname: Geoffroy
  surname: Canlorbe
  fullname: Canlorbe, Geoffroy
  email: geoffroy.canlorbe@aphp.fr
  organization: Institut Universitaire de Cancérologie (IUC), Paris, France
– sequence: 2
  givenname: Mathieu
  surname: Castela
  fullname: Castela, Mathieu
  organization: INSERM UMR S 938, University Pierre and Marie Curie, Paris, France
– sequence: 3
  givenname: Sofiane
  surname: Bendifallah
  fullname: Bendifallah, Sofiane
  organization: INSERM UMR S 707, Epidemiology, Information Systems, Modeling, University Pierre and Marie Curie, Paris, France
– sequence: 4
  givenname: Zhe
  surname: Wang
  fullname: Wang, Zhe
  organization: INSERM UMR S 938, University Pierre and Marie Curie, Paris, France
– sequence: 5
  givenname: Marine
  surname: Lefevre
  fullname: Lefevre, Marine
  organization: Faculté de médecine Paris 5 Descartes, Paris, France
– sequence: 6
  givenname: Nathalie
  surname: Chabbert-Buffet
  fullname: Chabbert-Buffet, Nathalie
  organization: INSERM UMR S 938, University Pierre and Marie Curie, Paris, France
– sequence: 7
  givenname: Selim
  surname: Aractingi
  fullname: Aractingi, Selim
  organization: Department of Dermatology, Cochin University Hospital, Assistance Publique des Hôpitaux de Paris, University René Descartes, Paris, France
– sequence: 8
  givenname: Emile
  surname: DaraÏ
  fullname: DaraÏ, Emile
  organization: INSERM UMR S 938, University Pierre and Marie Curie, Paris, France
– sequence: 9
  givenname: Céline
  surname: Méhats
  fullname: Méhats, Céline
  organization: INSERM U1016, CNRS 8104, Institut Cochin, University Paris Descartes, Paris, France
– sequence: 10
  givenname: Marcos
  surname: Ballester
  fullname: Ballester, Marcos
  organization: INSERM UMR S 938, University Pierre and Marie Curie, Paris, France
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28000202$$D View this record in MEDLINE/PubMed
BookMark eNo1j8tKxDAYRoMozkU3PoDkBaJJmqTJchjUCqOCjOvhb_pXK20a0gvM2zugrr5zNge-FTkPfUBCbgS_E8rk_L4omBDMandGlsI4x7RVdkFWw_DNuZRO60uykJafhMsl2b80PvXs_XVDh-YzwDglpH1N22MXv_oZBj-1kOgQwSNtwty3M3YYxhPT8RiRCoqh6jscUwMt9RA8pityUUM74PXfrsnH48N-W7Dd29PzdrNjUQoxstKAt6ZSKi8VlzazjkNplFKZqHxdld4ozCH3NYjKau-00BrrzOTa1A64kmty-9uNU9lhdYip6SAdD__35A8HEFEk
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.14670/HH-11-859
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Anatomy & Physiology
EISSN 1699-5848
ExternalDocumentID 28000202
Genre Journal Article
GroupedDBID ---
.GJ
53G
5GY
ADBBV
AENEX
ALMA_UNASSIGNED_HOLDINGS
BAWUL
CGR
CUY
CVF
DIK
EBS
ECM
EIF
EJD
F5P
HHO
KWQ
NPM
OK1
SJN
UDS
ID FETCH-LOGICAL-p211t-b6ac86d447b40283890ab644431dcfdbc64e7a7cfa1d85c95155ef36756f9a042
IngestDate Thu Jan 02 23:09:41 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 9
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-p211t-b6ac86d447b40283890ab644431dcfdbc64e7a7cfa1d85c95155ef36756f9a042
PMID 28000202
ParticipantIDs pubmed_primary_28000202
PublicationCentury 2000
PublicationDate 2017-09-01
PublicationDateYYYYMMDD 2017-09-01
PublicationDate_xml – month: 09
  year: 2017
  text: 2017-09-01
  day: 01
PublicationDecade 2010
PublicationPlace Spain
PublicationPlace_xml – name: Spain
PublicationTitle Histology and histopathology
PublicationTitleAlternate Histol Histopathol
PublicationYear 2017
SSID ssj0022955
Score 2.2336845
Snippet Lymphovascular space involvement (LVSI) is a major prognostic factor in type 1 endometrial cancer (EC). However, its use has been criticized because of poor...
SourceID pubmed
SourceType Index Database
StartPage 941
SubjectTerms Aged
Carcinoma, Endometrioid - genetics
Carcinoma, Endometrioid - metabolism
Carcinoma, Endometrioid - pathology
Endometrial Neoplasms - genetics
Endometrial Neoplasms - metabolism
Endometrial Neoplasms - pathology
Female
Humans
Lymphatic Metastasis - pathology
Lymphatic System - metabolism
Lymphatic System - pathology
Lymphatic Vessels - metabolism
Lymphatic Vessels - pathology
MicroRNAs - genetics
MicroRNAs - metabolism
Middle Aged
Neoplasm Staging
Title Micro-RNA signature of lymphovascular space involvement in type 1 endometrial cancer
URI https://www.ncbi.nlm.nih.gov/pubmed/28000202
Volume 32
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT-MwELbK7oULYpfnAisfVlyQoXXz8rFCoGolOCxFIC7IcWyBRJOKLQc47G_fb-w0DS_t4xJFsdJE_r6OZybjbxj7ZjSCBt1VQmHxFYi_-kJJqYRNi8hI42TqkT45TYbn0ffL-LLT-dXeXTLN983Tm_tK_gdVXAOutEv2H5BtfhQXcA58cQTCOP4VxidUTSd-nA72qAzDS3SS83f3CIjmNaawGYakQWCIvDh4aApAqdfeni2LamxD6w5DBLhve6teQ6TRaPLSxNTB-Fkm_lCXCPlzWyfYnbuvWmPg0J0Oe4KmN7f2oYn-8eBbR0l8n9Y5wzTo-Qf-izqJfXVj21kJrHSzsissKsGSJkoJeDdZ29TOU5kPs2LyYDdVUL96Zc9hxqkCcjik7X9Z0A5vATsZe2Rl5r-oyj-PvtDWng0tsAVEGdQ2lXI9dbguVRzXgrb0GgfNS5CAdH3ji2DEOyWjZbZURxN8EKjxiXVs-ZmtDECFavzId7mv7_VwrbBRwxbesIVXjj9nC_ds4S224JwTW3iPt9jCA1tW2fnx0ehwKOqeGmKCUH8q8kSbLCmiKM0jci0z1dU5fGL4kYVxRW6SyKY6NU73iiw2ijoAWddHWJk4_KcjucY-lFVpNxiHZxPHsq8Ko5Io61qdFc5SvzPd6-Z4wCZbD3NzPQnCKdezWfvy7sgWW5yzaZt9BBF_2h24fdP8q0fnN2lOWX8
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Micro-RNA+signature+of+lymphovascular+space+involvement+in+type+1+endometrial+cancer&rft.jtitle=Histology+and+histopathology&rft.au=Canlorbe%2C+Geoffroy&rft.au=Castela%2C+Mathieu&rft.au=Bendifallah%2C+Sofiane&rft.au=Wang%2C+Zhe&rft.date=2017-09-01&rft.eissn=1699-5848&rft.volume=32&rft.issue=9&rft.spage=941&rft_id=info:doi/10.14670%2FHH-11-859&rft_id=info%3Apmid%2F28000202&rft_id=info%3Apmid%2F28000202&rft.externalDocID=28000202